Phospho-Histone H3 (Thr118) Antibody

What is Phospho-Histone H3 (Thr118) and why is it significant in chromatin biology?

Phospho-Histone H3 (Thr118) refers to the phosphorylation of the threonine residue at position 118 of histone H3. This modification occurs at a critical position within the nucleosome structure at the histone-DNA interface and has significant implications for chromatin organization. Unlike many histone modifications that occur on the N- and C-terminal tails, H3 T118ph occurs within the globular domain at the nucleosomal dyad.

The significance of this modification lies in its ability to physically disrupt histone-DNA contacts. Biochemical studies have confirmed that H3 T118ph causes reduced nucleosome stability, increased nucleosome mobility, and enhanced DNA accessibility . This modification can alter chromatin structure to the extent that it generates novel populations of alternate DNA-histone complexes, termed nucleosome duplexes and altosomes .

What are the recommended applications for Phospho-Histone H3 (Thr118) Antibody?

Based on available product information, Phospho-Histone H3 (Thr118) Antibody can be utilized in multiple research applications:

The antibody typically demonstrates reactivity with human, mouse, and rat samples, making it versatile for comparative studies across these species . For optimal results, researchers should verify the specificity of the antibody through appropriate controls, particularly when studying the temporal dynamics of H3 T118 phosphorylation during cell cycle progression.

How is Phospho-Histone H3 (Thr118) regulated during the cell cycle?

Phosphorylation of histone H3 at threonine 118 is dynamically regulated during mitosis. Research has shown that Aurora-A kinase is responsible for this modification, with H3 T118ph appearing at pericentromeric regions and discrete locations on chromosome arms during prophase .

Importantly, this modification has a specific temporal profile during mitosis:

• H3 T118ph levels increase significantly as cells enter mitosis

• The modification is present at pericentromeres and chromosome arms during prophase

• H3 T118ph disappears from each chromosome when chromosome alignment is achieved

This dynamic regulation suggests that H3 T118ph plays a transient but crucial role in chromosome organization during specific phases of mitosis, potentially to enable efficient attachment to the mitotic spindle and effective chromosome compaction .

How does Phospho-Histone H3 (Thr118) influence nucleosome structure and chromatin compaction?

The phosphorylation of H3 T118 has profound effects on nucleosome structure due to its strategic location at the nucleosomal dyad where it directly affects histone-DNA interactions. Research demonstrates that H3 T118ph physically distorts the nucleosomal DNA at this position, leading to:

• Loosened nucleosome structure

• Generation of alternative nucleosomal states

• Increased DNA accessibility to nuclear factors

• Formation of novel nucleosome duplexes and altosomes

These alterations at the nucleosome level translate to higher-order effects on chromosome packaging. Excess H3 T118ph (achieved through Aurora-A overexpression or mimicked by amino acid substitution) results in:

• Altered chromosome compaction

• Cohesion defects

• Cohesin and condensin I loss

• Increased frequency of lagging chromosomes

• Defects in chromosome congression

• Delayed cytokinesis

These findings suggest that H3 T118ph modifies chromatin structure to limit condensin I and cohesin occupancy, which may be necessary for efficient spindle attachment and chromosome compaction during mitosis.

What is the relationship between Aurora-A kinase and Phospho-Histone H3 (Thr118) in mitotic regulation?

Aurora-A kinase has been identified as the enzyme responsible for phosphorylating histone H3 at threonine 118 during mitosis. This relationship is evidenced by several experimental findings:

• Overexpression of Aurora-A leads to increased H3 T118ph levels

• Both Aurora-A overexpression and H3 T118ph mimicking mutations (T118E/T118I) produce identical phenotypes

• These phenotypes include cohesion loss, reduced levels of cohesin and condensin I on chromatin, and mitotic defects

Mechanistically, Aurora-A mediated H3 T118 phosphorylation appears to influence chromosome dynamics by altering chromatin structure during specific phases of mitosis. This structural change promotes timely condensin I and cohesin disassociation, which is essential for effective chromosome segregation .

The fact that overexpression of Aurora-A (leading to excess H3 T118ph) causes mitotic defects highlights the importance of precise regulation of this modification during cell division.

How does Phospho-Histone H3 (Thr118) compare with other mitotic markers such as Phospho-Histone H3 (Ser10)?

While both are phosphorylation events on histone H3, Phospho-Histone H3 (Thr118) and Phospho-Histone H3 (Ser10) differ in several important ways:

Phospho-Histone H3 (Ser10) has been more extensively characterized as a mitotic marker and is frequently used in clinical applications. Studies have demonstrated that Phospho-Histone H3 (Ser10) antibodies provide superior specificity for detecting mitotic cells compared to traditional H&E staining or Ki-67 . PHH3 (Ser10) immunostaining has proven valuable for determining mitotic index in various cancers, including breast cancer, melanoma, meningiomas, and pancreatic neuroendocrine tumors .

What methodological considerations are important when using Phospho-Histone H3 (Thr118) Antibody for chromatin immunoprecipitation (ChIP)?

When conducting ChIP experiments with Phospho-Histone H3 (Thr118) Antibody, several critical methodological considerations should be addressed:

Sample preparation:

• Timing is crucial due to the transient nature of H3 T118ph during mitosis

• Cell synchronization methods may be necessary to enrich for mitotic cells

• Cross-linking conditions may need optimization to preserve the phospho-epitope

Buffer composition:

• Avoid buffers containing phosphate when detecting phosphoproteins

• Include phosphatase inhibitors in all buffers to prevent dephosphorylation

• Use detergent concentrations that don't interfere with antibody-epitope interactions

Controls:

• Include appropriate positive controls such as mitotic cell extracts where H3 T118ph is enriched

• Use negative controls such as lambda phosphatase-treated samples

• Consider using H3 T118 phospho-mimetic mutants (T118E/T118I) as reference points

Validation methods:

• Confirm antibody specificity using dot-blot assays as shown in published research

• Verify enrichment through western blotting before proceeding to ChIP-seq analysis

• Compare results with other known mitotic markers like H3 Ser10ph for correlation

For optimal results, researchers should also consider the dynamic nature of this modification during the cell cycle and design experiments to capture cells at specific mitotic stages.

What role does Phospho-Histone H3 (Thr118) play in cohesion and chromosomal dynamics during mitosis?

Research indicates that Phospho-Histone H3 (Thr118) plays a critical role in regulating sister chromatid cohesion and chromosomal dynamics during mitosis. Key findings include:

• Cohesion regulation: Excess H3 T118ph (caused by overexpression of Aurora-A or mimicked by T118E/T118I mutations) leads to premature loss of cohesion between sister chromatids .

• Cohesin dissociation: H3 T118ph appears to promote the dissociation of cohesin complex proteins from chromosomes. Studies show that Rad21/Scc1 (a component of the cohesin complex) is drastically reduced along chromosome arms and at centromeres in cells expressing H3 T118E and T118I .

• Mechanism of cohesin removal: The cohesion loss caused by H3 T118ph is not due to premature separase activity but occurs through the PLK-1 or Aurora-B mediated pathway. This was demonstrated by experiments showing that cohesion loss in H3 T118E/I mutants was prevented by PLK-1 inhibitor (BI2536) and Aurora-B inhibitor (hesperidin) .

• Condensin I regulation: H3 T118ph also influences condensin I localization on chromosomes, which is critical for proper chromosome compaction and rigidity at the centromere .

The proposed model suggests that H3 T118ph alters chromatin structure to regulate condensin I and cohesin occupancy in a temporally controlled manner during mitosis, which is essential for efficient spindle attachment and effective chromosome segregation .

How can researchers troubleshoot specificity issues with Phospho-Histone H3 (Thr118) Antibody detection?

When encountering specificity issues with Phospho-Histone H3 (Thr118) Antibody, researchers should implement the following troubleshooting strategies:

Antibody validation:

• Perform dot-blot assays with phosphorylated and non-phosphorylated peptides to confirm specificity

• Test antibody recognition in western blots using calyculin A (phosphatase inhibitor) treated versus untreated cells

• Verify single band recognition at the expected molecular weight (approximately 17 kDa)

Cross-reactivity assessment:

• Test antibody against related phosphorylation sites on histone H3 (T6, T11, S10, S28)

• Conduct peptide competition assays with the immunizing phosphopeptide

• Examine reactivity in phosphatase-treated samples as negative controls

Optimization strategies:

• Adjust antibody concentration (typical working dilutions range from 1:100 to 1:1000)

• Modify blocking conditions to reduce background signal

• Test different detection methods (direct fluorescence vs. amplification systems)

• Optimize fixation protocols to preserve the phospho-epitope

• Include appropriate positive controls (mitotic cell extracts)

For immunofluorescence applications specifically, consider cell cycle synchronization to enrich for mitotic cells where H3 T118ph is more abundant, and co-stain with established mitotic markers to confirm specificity of detection.

What are the implications of Phospho-Histone H3 (Thr118) in development and disease models?

Research indicates several important implications of Phospho-Histone H3 (Thr118) in development and disease:

Developmental requirements:

• H3 T118ph is required for normal development in fruit flies, indicating its evolutionary conservation and essential function

• Cell clones expressing only H3 T118A (preventing phosphorylation) in Drosophila show significant defects in cell growth

Cell division and genomic stability:

• Dysregulation of H3 T118ph leads to mitotic defects including lagging chromosomes, defects in chromosome congression, delayed cytokinesis, and cohesion loss

• These defects can potentially contribute to chromosomal instability and aneuploidy, hallmarks of many cancers

Cancer implications:

• Given the role of Aurora-A as the kinase responsible for H3 T118 phosphorylation, and the fact that Aurora-A is frequently overexpressed in various cancers, aberrant H3 T118ph may contribute to oncogenesis

• The cohesion defects caused by excess H3 T118ph could lead to chromosome missegregation, a common feature in cancers

• Altering chromosome structure through H3 T118ph may impact gene expression patterns relevant to cellular transformation

Potential therapeutic relevance:

• Understanding the relationship between Aurora-A and H3 T118ph could inform the development of more targeted Aurora kinase inhibitors

• Monitoring H3 T118ph levels might serve as a biomarker for Aurora-A activity in clinical samples

• The mitotic roles of H3 T118ph suggest it could be relevant to the efficacy of anti-mitotic cancer therapies

Future research should explore these implications in greater detail, particularly regarding the potential role of H3 T118ph in cancer development and progression.

What are the best experimental approaches for studying the functional consequences of Phospho-Histone H3 (Thr118)?

To study the functional consequences of Phospho-Histone H3 (Thr118), researchers have employed several complementary approaches:

Genetic substitution approaches:

• Generation of histone H3 mutants (T118A, T118E, T118I) to prevent phosphorylation or mimic its effects

• Integration of these mutants into cellular systems at controlled expression levels

• Comparative analysis of phenotypes between wild-type and mutant cells

Kinase modulation:

• Overexpression of Aurora-A kinase to increase H3 T118ph levels

• Use of Aurora-A kinase inhibitors to reduce H3 T118ph

• Correlation of kinase activity with H3 T118ph levels and cellular phenotypes

Microscopy analysis:

• Immunofluorescence to localize H3 T118ph during different cell cycle stages

• Live-cell imaging to track chromosome dynamics in cells with altered H3 T118ph

• Super-resolution microscopy to examine chromatin structural changes

Biochemical assays:

• In vitro nucleosome assays to assess the impact of H3 T118ph on nucleosome stability

• Chromatin immunoprecipitation to map genomic locations of H3 T118ph

• Protein association studies to identify factors that interact with or are displaced by H3 T118ph

Functional mitotic assays:

• Mitotic spread analysis to assess sister chromatid cohesion

• Spindle attachment assays to evaluate chromosome-microtubule interactions

• Cytokinesis analysis to determine completion of cell division

Model organism studies:

• Drosophila development models to assess in vivo relevance

• Cell-based assays to establish evolutionary conservation of H3 T118ph function

• Tissue-specific expression of H3 T118 mutants to determine context-dependent effects

The combination of these approaches provides a comprehensive understanding of how H3 T118ph influences chromatin structure, mitotic progression, and cellular physiology.

How can researchers accurately quantify Phospho-Histone H3 (Thr118) levels in experimental samples?

Accurate quantification of Phospho-Histone H3 (Thr118) levels requires careful methodology selection and rigorous controls. The following approaches are recommended:

Western blot quantification:

• Use purified recombinant H3 T118ph peptides as standards for calibration curves

• Normalize to total histone H3 levels to account for variations in histone content

• Employ highly specific antibodies validated with dot-blot assays

• Include phosphatase-treated controls to confirm phospho-specificity

• Use infrared fluorescence-based detection systems for improved linear range

Mass spectrometry approaches:

• Utilize targeted LC-MS/MS methods with isotopically labeled internal standards

• Develop multiple reaction monitoring (MRM) assays specific for H3 T118ph peptides

• Implement parallel reaction monitoring (PRM) for increased specificity

• Consider chemical derivatization strategies to enhance detection sensitivity

• Analyze both phosphorylated and unmodified peptides to determine stoichiometry

ELISA or AlphaLISA assays:

• Develop sandwich immunoassays using antibodies against H3 and H3 T118ph

• Establish standard curves with synthetic phosphopeptides

• Optimize extraction conditions to ensure complete solubilization of histones

• Validate assay performance across different sample types

Flow cytometry:

• Combine with cell cycle markers to correlate H3 T118ph with specific cell cycle phases

• Use appropriate permeabilization protocols to ensure antibody access to nucleosomes

• Include single-color controls for accurate compensation

• Consider multiparameter analysis to correlate with other mitotic markers

Microscopy-based quantification:

• Standardize image acquisition parameters for consistent analysis

• Develop automated image analysis pipelines for objective quantification

• Use reference standards on each slide for normalization between experiments

• Consider z-stack acquisition to capture the full nuclear volume